03/23/16 10:40 AM H.R. 2745
On motion to recommit with instructions Roll Call 136 - Yea and Nay vote pending.
03/23/16 10:40 AM H.R. 2745
The previous question on the motion to recommit with instructions was ordered without objection.
03/23/16 10:32 AM H.R. 2745
DEBATE - The House proceeded with ten minutes of debate on the motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment to prohibit mergers that would increase the costs of pharmaceutical drugs.
03/23/16 10:32 AM H.R. 2745
DEBATE - The House proceeded with ten minutes of debate on the motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment to prohibit mergers that would increase the costs of pharaceutical drugs.
03/23/16 10:32 AM H.R. 2745
Floor summary: DEBATE - The House proceeded with ten minutes of debate on the motion to recommit with instructions.
03/23/16 10:32 AM H.R. 2745
Mr. Doggett moved to recommit with instructions to the Committee on the Judiciary.
03/23/16 10:31 AM H.R. 2745
The previous question was ordered pursuant to the rule.
03/23/16 9:42 AM H.R. 2745
DEBATE - The House proceeded with one hour of debate on H.R. 2745.
03/23/16 9:40 AM H.R. 2745
Rule provides for consideration of H.R. 2745 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit. Measure will be considered read. Bill is closed to amendments. On any legislative day during the period from March 24, 2016, through April 11, 2016, the Journal of the proceedings of the previous day shall be considered as approved; and the Chair may at any time declare the house adjourned to meet at a date and time, within the limits of clause 4, section 5, of article I of the Constitution, to be announced by the Chair in declaring the adjournment.
03/23/16 9:40 AM H.R. 2745
Considered under the provisions of rule H. Res. 653. H.R. 2745 — "To amend the Clayton Act and the Federal Trade Commission Act to provide that the Federal Trade Commission shall exercise authority with respect to mergers only under the Clayton Act and only in the same procedural manner as the Attorney General exercises such authority."
